Lowey Dannenberg Notifies TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ: TMDX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the FirmNEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against TransMedics Group, Inc. (“TransMedics” or the “Company”) (
NASDAQTMDX) for violations of the federal securities laws on behalf of investors who purchased or acquired TransMedics common stock between February 28, 2023 and January 10, 2025, inclusive (the “Class Period”).
Kessler Topaz Meltzer & Check, LLP Reminds TransMedics Group, Inc. Investors of Important Deadline in Securities Fraud Class Action LawsuitSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kessler Topaz Meltzer & Check, LLP Reminds TransMedics Group, Inc. Investors of Important Deadline in Securities Fraud Class Action LawsuitRADNOR, PA - February 27, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against TransMedics Group, Inc. (“TransMedics”) (
NASDAQTMDX) on behalf of those who purchased or otherwise acquired TransMedics securities between February 28, 2023, and January 10, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is April 15, 2025.
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of TransMedics GroupFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In TransMedics To Contact Him Directly To Discuss Their Options
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FMC, TransMedics, Alarum, and Constellation and Encourages Investors to Contact the FirmNEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of FMC Corporation (
NYSEFMC), TransMedics Group, Inc.
NASDAQ:TMDXNASDAQTMDX)
(NASDAQ: ALARNASDAQALAR
, and Constellation Brands, Inc. (NYSE:STZNYSE
). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
TMDX Shareholders with Large Losses Should Contact Robbins LLP for Information About the Securities Class Action Against TransMedics Group, Inc.SAN DIEGO, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons or entities who purchased or otherwise acquired TransMedics Group, Inc. (
NASDAQTMDX) securities between February 28, 2023 and January 10, 2025. TransMedics describes itself as a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states.
Lowey Dannenberg Notifies TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ: TMDX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the FirmNEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against TransMedics Group, Inc. (“TransMedics” or the “Company”) (
NASDAQTMDX) for violations of the federal securities laws on behalf of investors who purchased or acquired TransMedics common stock between February 28, 2023 and January 10, 2025, inclusive (the “Class Period”).
TMDX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against TransMedics Group, Inc. (“TransMedics” or “the Company”) (
NASDAQTMDX) and certain of its officers.
TMDX Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against TransMedics Group, Inc. (TMDX)RADNOR, PA - February 21, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against TransMedics Group, Inc. (“TransMedics”) (
NASDAQTMDX) on behalf of those who purchased or otherwise acquired TransMedics securities between February 28, 2023, and January 10, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is April 15, 2025.
Class Action Announcement TMDX: A Securities Fraud Class Action Lawsuit Was Filed Against TransMedics Group, Inc. (TMDX) - Contact Kessler Topaz Meltzer & Check, LLP
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against TransMedics Group, Inc. (“TransMedics”) (
NASDAQTMDX) on behalf of those who purchased or otherwise acquired TransMedics securities between February 28, 2023, and January 10, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is April 15, 2025.
Class Action Announcement for TransMedics Group, Inc. (TMDX): Kessler Topaz Meltzer & Check, LLP Announces That a Securities Class Action Lawsuit Has Been Filed Against TransMedics Group, Inc.RADNOR, PA - February 19, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against TransMedics Group, Inc. (“TransMedics”) (
NASDAQTMDX) on behalf of those who purchased or otherwise acquired TransMedics securities between February 28, 2023, and January 10, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is April 15, 2025.
TMDX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of TransMedics Group, Inc. (
NASDAQTMDX) publicly traded securities between February 28, 2023 and January 10, 2025, both dates inclusive (the “Class Period”), have until April 15, 2025 to seek appointment as lead plaintiff of the TransMedics class action lawsuit. Captioned Jewik v. TransMedics Group, Inc., No. 25-cv-10385 (D. Mass.), the TransMedics class action lawsuit charges TransMedics as well as certain of TransMedics’ top executives with violations of the Securities Exchange Act of 1934.
INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against TransMedics Group, Inc. (NASDAQ: TMDX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with CounselSAN DIEGO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of all persons and entities who purchased or otherwise acquired TransMedics Group, Inc. (
NASDAQTMDX) (“TransMedics” or the “Company”) securities between February 28, 2023 and January 10, 2025 (the “Class Period”), charging the Company and certain senior executives with violations of the federal securities laws (collectively, “Defendants”).
TRANSMEDICS GROUP, INC. (NASDAQ: TMDX) INVESTOR ALERT: Investors With Large Losses in TransMedics Group, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their RightsNEW YORK, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of TransMedics Group, Inc. (“TransMedics” or the “Company”) (
NASDAQTMDX) between February 28, 2023 and January 10, 2025, inclusive.
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of TransMedics GroupFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In TransMedics To Contact Him Directly To Discuss Their Options
TransMedics Group, Inc. Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Against TMDXSAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons or entities who purchased or otherwise acquired TransMedics Group, Inc. (
NASDAQTMDX) securities between February 28, 2023 and January 10, 2025. TransMedics describes itself as a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states.
TRANSMEDICS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against TransMedics Group, Inc. and Encourages Investors to Contact the FirmNEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against TransMedics Group, Inc. (“TransMedics” or the “Company”) (
NASDAQTMDX) in the United States District Court for the District of Massachusetts on behalf of all persons and entities who purchased or otherwise acquired TransMedics securities between February 28, 2023 and January 10, 2025, both dates inclusive (the “Class Period”). Investors have until April 15, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
TMDX ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of TransMedics Group, Inc. Investors
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired TransMedics Group, Inc. (“TransMedics” or the “Company”) (
NASDAQTMDX) securities during the period from February 28, 2023, through January 10, 2025 (“the Class Period”). Investors have until April 15, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of TransMedics Group
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against TransMedics Group, Inc. (“TransMedics” or the “Company”) (
NASDAQTMDX) and reminds investors of the April 15, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Lowey Dannenberg, P.C. is Investigating TransMedics Group, Inc. (NASDAQ:TMDX) for Potential Violations of the Federal Securities LawsNEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating TransMedics Group, Inc. (“TransMedics”) (
NASDAQTMDX) for potential violations of the federal securities laws.
